Jeffrey Richard Enders

Development and validation of a high resolving power absolute quantitative per- and polyfluoroalkyl substances method incorporating Skyline data processing

RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 36(11).

Monitoring decellularization via absorbance spectroscopy during the derivation of extracellular matrix scaffolds

BIOMEDICAL MATERIALS, 17(1).

Recovery of per- and polyfluoroalkyl substances after solvent evaporation

Weed, R. A., Boatman, A. K., & Enders, J. R. (2022, October 14). ENVIRONMENTAL SCIENCE-PROCESSES & IMPACTS, Vol. 10.

Altered glucuronidation deregulates androgen dependent response profiles and signifies castration resistance in prostate cancer

Oncotarget, 12(19), 1886–1902.

Design, synthesis, and evaluation of substrate - analogue inhibitors of Trypanosoma cruzi ribose 5-phosphate isomerase type B

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 32.

Ritalinic acid in urine: Impact of age and dose

PRACTICAL LABORATORY MEDICINE, 27.

Understanding the electrospray ionization response factors of per- and poly-fluoroalkyl substances (PFAS)

Enders, J. R., Grace M. O'Neill, Whitten, J. L., & Muddiman, D. C. (2021, July 21). ANALYTICAL AND BIOANALYTICAL CHEMISTRY, Vol. 7.

A Dilute and Shoot LC-MS/MS Method for Antipsychotics in Urine

JOURNAL OF ANALYTICAL TOXICOLOGY, 44(4), 331–338.

Fast Automated Approach for the Derivation of Acellular Extracellular Matrix Scaffolds from Porcine Soft Tissues.

ACS Biomaterials Science & Engineering, 6(7), 4200–4213.

Porcine Vocal Fold Lamina Propria-Derived Biomaterials Modulate TGF-β1-Mediated Fibroblast Activation in Vitro.

ACS Biomaterials Science & Engineering, 6(3), 1690–1703.

A Dilute-and-Shoot LC-MS/MS Method for Antipsychotics in Urine

Feng, S., Enders, J., Cummings, O. T., Strickland, E. C., McIntire, T., & McIntire, G. (2019, October). Presented at the Society of Forensic Toxicology (SOFT) Annual Meeting, San Antonio, TX.

A Proteomic Investigation of Changes in the Collagen Types Present in the Anterior Cruciate Ligament During Post-natal Growth

Enders, J. R., Cone, S. G., & Fisher, M. B. (2019, June). Presented at the American Society for Mass Spectrometry (ASMS) Annual Conference, Atlanta, GA.

Determination of the Relative Prevalence of Lurasidone Metabolites in Urine Using Untargeted HRMS

Current Trends in Mass Spectrometry, 17(2), 8–15. http://www.spectroscopyonline.com/determination-relative-prevalence-lurasidone-metabolites-urine-using-untargeted-hrms-0

Experimental data demonstrating the effects of silver nanoparticles on basement membrane gene and protein expression in cultured colon, mammary and bronchial epithelia

Yeyeodu, S. T., Martin, M. E., Reaves, D. K., Enders, J. R., Costantini, L. M., & Fleming, J. M. (2019, October). DATA IN BRIEF, Vol. 26.

Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-β1 secretion

Nanomedicine: Nanotechnology, Biology and Medicine, 21, 102070.

Alginate-encapsulated primary human hepatocyte culture system to increase the accuracy of the predicted in vivo half-life of low clearance compounds

Drug Metabolism and Pharmacokinetics, 33(1), S69–S70.

Analytical Considerations When Developing an LC-MS/MS Method for Over 30 Analytes

The Journal of Applied Laboratory Medicine, 2(4), 543–554.

Impact of β-Glucuronidase Mediated Hydrolysis on Haldol® Urinalysis

Journal of Analytical Toxicology, 42(4), 214–219.

Investigation of a targeted protein panel of diagnostic and prognostic value to ALS in biological fluids

Enders, J. (2018, June). Presented at the Qualitative Biomarkers, The American Society for Mass Spectrometry (ASMS) Annual Conference, San Diego, CA.

Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS

SCIENTIFIC REPORTS, 8(1).

NORMALIZING MEASURED DRUG CONCENTRATIONS IN ORAL FLUIDS AND TESTING FOR POTENTIAL NON-COMPLIANCE WITH DRUG TREATMENT REGIMEN

https://www.lens.org/109-358-919-977-271

Normalizing measured drug concentrations in oral fluids and testing for potential non-compliance with drug treatment regimen

(U.S. Patent Application Number No. 2018/20180045744 A1.).

Xenobiotic Metabolism in Alginate-Encapsulated Primary Human Hepatocytes over Long Timeframes

Applied In Vitro Toxicology, 4(3), 238–247.

Evaluation of Non-Specific Binding to Different Organic Polymeric Components in Flow-Based Advanced Cell Culture Systems for Toxicity Testing

Enders, J. R., Balbuena-Venancio, P., Billings, D., Rao, L., Burgunder, E., Phillips, M., & Yoon, M. (2017, March). Presented at the Society of Toxicology (SOT) Annual Conference, Baltimore, MD.

Identification of metabolites of brexpiprazole in human urine for use in monitoring patient compliance

Clinical Mass Spectrometry, 6, 21–24.

METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY

https://www.lens.org/119-736-087-516-250

METHODS OF MONITORING FOR ADHERENCE TO BREXPIPRAZOLE (REXULTI®) THERAPY

https://www.lens.org/141-517-997-208-481

Methods of Monitoring Adherence to Lurasidone Therapy

(U.S. Patent No. 2015/0168431 A1).

Methods of Monitoring for Adherence to Brexpiprazole (Rexulti®) Therapy

(U.S. Patent Application No. 2017/0276692 A1).

Methods of monitoring adherence to lurasidone therapy

https://www.lens.org/102-095-827-858-797

Response to: Fentanyl-Norfentanyl concentrations during transdermal patch application: LC-MS-MS urine analysis

Journal of Analytical Toxicology, 41(2), 165–166. http://www.scopus.com/inward/record.url?eid=2-s2.0-85019570326&partnerID=MN8TOARS

Fentanyl-norfentanyl concentrations during transdermal patch application: LC-MS-MS urine analysis

Journal of Analytical Toxicology, 40(8), 595–600.

Fentanyl—Norfentanyl Concentrations During Transdermal Patch Application: LC-MS/MS Urine Analysis

Presented at the Society of Forensic Toxicology (SOFT) Annual Meeting, Dallas, TX.

Improved chiral separation of methamphetamine enantiomers using CSP-LC-MS-MS

Journal of Analytical Toxicology, 40(4), 255–263.

Investigation of a Large Pain Profile from Fingerstick Capillary Blood

New Approaches to Pain Medication Compliance Monitoring. Presented at the Association for Mass Spectrometry and Advances in the Clinical Lab (MSACL) 2016 US: 8th Annual Congress and Exhibits, Palm Springs, CA.

NORMALIZING MEASURED DRUG CONCENTRATIONS IN ORAL FLUIDS AND TESTING FOR POTENTIAL NON-COMPLIANCE WITH DRUG TREATMENT REGIMEN

https://www.lens.org/173-764-751-938-731

Normalizing oral fluid hydrocodone data using calculated blood volume

Journal of Analytical Toxicology, 40(7), 486–491.

The synthetic cannabinoid chemical arms race and its effect on pain medication monitoring

LC-GC North America, 34(4), 15–22.

A dilute-and-shoot LC-MS method for quantitating opioids in oral fluid

Journal of Analytical Toxicology, 39(8), 662–667.

An Initial Look at Ketamine and Norketamine: Levels in a Pain Management Population

ToxTalk, 39(3), 7–10. https://www.soft-tox.org/files/toxtalk/SOFT_ToxTalk_v39-3.pdf

Haldol Analysis in Urine: The Impact of Beta-Glucuronidase Hydrolysis

ToxTalk, 39(3), 12–14. https://www.soft-tox.org/files/toxtalk/SOFT_ToxTalk_v39-3.pdf

METHODS OF MONITORING ADHERENCE TO LURASIDONE THERAPY

https://www.lens.org/142-044-808-933-676

Rapid Analysis of Selected Benzodiazepines by Automated SPE-MS/MS

Current Trends in Mass Spectrometry, 13(2), 8–15. https://www.chromatographyonline.com/view/rapid-analysis-selected-benzodiazepines-automated-spe-ms-ms

Rapid Mass Spectrometry Based Urine Drug Screening of 27 Antipsychotic and Antidepressant Medications

Presented at the Association for Mass Spectrometry Applications to the Clinical Lab (MSACL) 7th Annual Conference, San Diego, CA.

Real-time cellular exometabolome analysis with a microfluidic-mass spectrometry platform

PLoS ONE, 10(2).

Cross-Platform Comparison of Rapid Benzodiazepine Analyses

Presented at the Society of Forensic Toxicology (SOFT) Annual Meeting, Grand Rapids, MI.

Easy to Automate Extraction of THC Metabolites for LC-MS/MS Analysis

Presented at the Association for Mass Spectrometry Applications to the Clinical Lab (MSACL) Annual Conference, San Diego, CA.

Oral Fluid Pain Management Panel by "Dilute and Shoot" LC-MS/MS

Presented at the Association for Mass Spectrometry Applications to the Clinical Lab (MSACL) Annual Conference, San Diego, CA.

Oral Fluid Testing for Buprenorphine and THC by "Dilute and Shoot LC-MS/MS

Presented at the 62nd American Society for Mass Spectrometry (ASMS) Annual Conference, Baltimore, MD.

Oral Fluid Testing for Opiates by Dilute and Shoot LC-MS/MS

Presented at the Society of Forensic Toxicology (SOFT) Annual Meeting, Grand Rapids, MI.

Quantitative Analysis using Rapid Technologies

(2014, October). In Rapid Urine Drug Testing by Mass Spectrometry. Workshop presented at the Society of Forensic Toxicology (SOFT) Annual Meeting, Grand Rapids, MI.

Rapid Analysis of Selected Benzodiazepines by Automated SPE/MS/MS

Presented at the Association for Mass Spectrometry Applications to the Clinical Lab (MSACL) Annual Conference, San Diego, CA.

Screening Analysis of Heroin Samples for Possible Cutting Agents and Adulterants

ToxTalk, 38(3), 12–16. https://www.soft-tox.org/files/toxtalk/SOFT_ToxTalk_v38-3.pdf

A Quantitative Inspection of ESI Glucuronide Degradation

Presented at the 61st American Society for Mass Spectrometry Annual Conference, Minneapolis, MN.

A Dual-Column Solid Phase Extraction Strategy for Online Collection and Preparation of Continuously Flowing Effluent Streams for Mass Spectrometry

Analytical Chemistry, 84(20), 8467–8474.

Development of a Platform for Online Analysis of the Metabolic Footprint

Presented at the Association for Mass Spectrometry: Applications to the Clinical Laboratory (MSACL) Annual Conference, San Diego, CA.

Multidimensional Separations by Ion Mobility-Mass Spectrometry

Online analysis of a constant-perfusion cell culture microfluidic device for exometabolomic measurements

Presented at the 60th American Society for Mass Spectrometry Annual Conference, Vancouver, BC.

Strategies and Challenges in Dynamic Systems Biology Analysis Using Structural Mass Spectrometry”

Strategies and Challenges in Dynamic Systems Biology Analysis Using Structural Mass Spectrometry.” Ion Mobility MS: Applying Ion Mobility-Mass Spectrometry to Challenges in Proteomics and Systems Biology. Workshop presented at the American Society for Mass Spectrometry (ASMS) Annual Conference, Vancouver, BC Canada.

A Microfluidic-Ion Mobility-Mass Spectrometry Platform for Presymptomatic Diagnoses of CBW Agent Exposure

Presented at the 2011 Chemical and Biological Defense Science and Technology Conference, Las Vegas, NV.

Advanced Structural Mass Spectrometry for Systems Biology: Pulling the Needles from Haystacks

Current Trends in Mass Spectrometry, 9(3), 18–23.

Development of a Platform for Online Acquisition of Empirical Systems Biology Data

Presented at the 5th Annual Conference on Cellular Information Processing (q-bio), Santa Fe, NM.

Microfluidic-Coupled Ion Mobility-Mass Spectrometry Platform for Real-Time, Temporally-Resolved Analysis of Excreted Cellular Materials

Presented at the 59th American Society for Mass Spectrometry Annual Conference, Denver, CO.

Peptide and Protein Analysis Using Ion Mobility-Mass Spectrometry

In Protein and Peptide Mass Spectrometry in Drug Discovery (pp. 139–174).

Advanced Structural Mass Spectrometry for Systems Biology – Towards Presymptomatic Diagnosis of Threat Agent Exposure

Presented at the Chemical and Biological Defense Science & Technology Conference, Orlando, FL.

Characterizing the Saccharomyces cerevisiae respiratory oscillation exometabolome by ion mobility-mass spectrometry

Presented at the Quantitative Understanding in Biology (q-bio) Annual Conference, Santa Fe, NM.

Development of a Multi-Channel Ion Mobility-Mass Spectrometer for High-Throughput Interrogation of Cellular Response

Presented at the Quantitative Understanding in Biology (q-bio) Annual Conference, Santa Fe, NM.

Development of a Multiplexed (8-Channel) Ion Mobility-Mass Spectrometer Chemical Analyzer for Rapid Interrogation of Biochemical Response

Presented at the Chemical and Biological Defense Science & Technology Conference, Orlando, FL.

High-Throughput Ion Mobility-Mass Spectrometry Strategies for Monitoring Cellular Response in Real Time

Presented at the 58th Annual American Society for Mass Spectrometry Annual Conference, Salt Lake City, UT.

Investigating Leukocyte Dynamic Response to Stimuli in an Integrated Microfluidic-Ion Mobility-Mass Spectrometer

Presented at the Quantitative Understanding in Biology (q-bio) Annual Conference, Santa Fe, NM.

Structurally selective imaging mass spectrometry by imaging ion mobility-mass spectrometry

In Methods in Molecular Biology (Vol. 656, pp. 363–383).

Temporal Analysis of Biological Fluid for the Analysis of Cellular Signaling and Response Using Ion Mobility-mass Spectrometry Analyses

Presented at the Chemical and Biological Defense Science & Technology conference, Orlando, FL.

Towards monitoring real-time cellular response using an integrated microfluidics-matrix assisted laser desorption ionisation/nanoelectrospray ionisation-ion mobility-mass spectrometry platform

IET Systems Biology, 4(6), 416–427.

Chiral and structural analysis of biomolecules using mass spectrometry and ion mobility-mass spectrometry

Chirality, 21(1 E).

Combining microfluidic cell trapping with real time monitoring of biomolecular exudates by ion mobility-mass spectrometry

Presented at the American Society for Mass Spectrometry Annual Conference, Philadelphia, PA.

Measuring real-time cellular responses to chemical and biological warfare agents using structural mass spectrometry techniques

Presented at the Chemical and Biological Defense Science and Technology (CBD S&T) Conference, Dallas, TX.

Microfluidic-ion mobility-mass spectrometry for assessing cellular response in real time

Presented at the Quantitative Understanding in Biology (q-bio) Annual Conference, Santa Fe, NM.

Microfluidic-ion mobility-mass spectrometry for assessing cellular response in real time

Presented at the Quantitative Understanding in Biology (q-bio) Annual Conference, Santa Fe, NM.

Real time analysis of cell signaling and response using microfluidic cell trapping-ion mobility-mass spectrometry

Presented at the Federation of Analytical Chemistry and Spectroscopy Societies Conference, Louisville, KY.

Dynamic Biomolecular Measurements of Cellular Response by Ion Mobility-Mass Spectrometry: A New Strategy for Systems Biology

Presented at the Southeast Regional Meeting of the American Chemical Society, Nashville, TN.

Ion Mobility Mass Spectrometry of the products of oligomerization of activated nucleotides with Montmorillonite

Presented at the American Society for Mass Spectrometry Annual Conference, Denver, CO.